GP
PFE icon

Guardian Partners’s Pfizer PFE Stock Holding History

Guardian Partners’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.13M Sell
46,810
-20,911
-31% -$547K 0.1% 107
2026
Q1 		$1.91M Buy
67,721
+316
+0.5% +$8.41K 0.16% 89
2025
Q4 		$1.8M Buy
67,405
+100
+0.1% +$2.52K 0.14% 99
2025
Q3 		$1.83M Buy
67,305
+10
+0% +$247 0.16% 93
2025
Q2 		$1.72M Sell
67,295
-79,416
-54% -$1.85M 0.15% 97
2025
Q1 		$3.28M Buy
146,711
+18,060
+14% +$473K 0.34% 74
2024
Q4 		$3.46M Buy
+128,651
New +$3.49M 0.35% 69

Other funds holding PFE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Guardian Partners's PFE Position: Q2 2026 in Review

Guardian Partners reduced its Pfizer (PFE) stake by 31% in Q2 2026, selling an estimated $547K and leaving 46,810 shares worth $1.13M. The position accounts for 0.1% of the portfolio, ranked #107.

Guardian Partners first reported a position in PFE in Q4 2024 and has held it in 7 quarters since. The position peaked at $3.46M in Q4 2024. 2,830 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Guardian Partners held 46,810 shares of Pfizer worth $1.13M as of Q2 2026.
  • Guardian Partners sold 20,911 Pfizer shares in Q2 2026, an estimated $547K.
  • Pfizer made up 0.1% of Guardian Partners's portfolio in Q2 2026, its #107 holding.
  • Guardian Partners first reported a position in Pfizer in Q4 2024 and has held it in 7 quarters since.
  • Guardian Partners's Pfizer position peaked at $3.46M in Q4 2024.
  • 2,830 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Guardian Partners's 13F filing for Q2 2026, filed 29 Jul 2026.